List of Tables
Table 1. Global Erlotinib Generics Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Erlotinib Generics Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Erlotinib Generics Market Competitive Situation by Manufacturers in 2025
Table 4. Global Erlotinib Generics Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Erlotinib Generics Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Erlotinib Generics Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Erlotinib Generics Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Erlotinib Generics Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Erlotinib Generics, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Erlotinib Generics, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Erlotinib Generics, Product Types and Applications
Table 12. Global Key Manufacturers of Erlotinib Generics, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Erlotinib Generics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Erlotinib Generics Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Erlotinib Generics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Erlotinib Generics Sales by Region (K Units), 2021–2026
Table 18. Global Erlotinib Generics Sales Market Share by Region (2021–2026)
Table 19. Global Erlotinib Generics Sales by Region (K Units), 2027–2032
Table 20. Global Erlotinib Generics Sales Market Share by Region (2027–2032)
Table 21. Global Erlotinib Generics Revenue by Region (US$ Million), 2021–2026
Table 22. Global Erlotinib Generics Revenue Market Share by Region (2021–2026)
Table 23. Global Erlotinib Generics Revenue by Region (US$ Million), 2027–2032
Table 24. Global Erlotinib Generics Revenue Market Share by Region (2027–2032)
Table 25. North America Erlotinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Erlotinib Generics Sales by Country (K Units), 2021–2026
Table 27. North America Erlotinib Generics Sales by Country (K Units), 2027–2032
Table 28. North America Erlotinib Generics Revenue by Country (US$ Million), 2021–2026
Table 29. North America Erlotinib Generics Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Erlotinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Erlotinib Generics Sales by Country (K Units), 2021–2026
Table 32. Europe Erlotinib Generics Sales by Country (K Units), 2027–2032
Table 33. Europe Erlotinib Generics Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Erlotinib Generics Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Erlotinib Generics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Erlotinib Generics Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Erlotinib Generics Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Erlotinib Generics Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Erlotinib Generics Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Erlotinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Erlotinib Generics Sales by Country (K Units), 2021–2026
Table 42. Latin America Erlotinib Generics Sales by Country (K Units), 2027–2032
Table 43. Latin America Erlotinib Generics Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Erlotinib Generics Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Erlotinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Erlotinib Generics Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Erlotinib Generics Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Erlotinib Generics Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Erlotinib Generics Revenue by Country (US$ Million), 2027–2032
Table 50. Global Erlotinib Generics Sales (K Units) by Type (2021–2026)
Table 51. Global Erlotinib Generics Sales (K Units) by Type (2027–2032)
Table 52. Global Erlotinib Generics Sales Market Share by Type (2021–2026)
Table 53. Global Erlotinib Generics Sales Market Share by Type (2027–2032)
Table 54. Global Erlotinib Generics Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Erlotinib Generics Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Erlotinib Generics Revenue Market Share by Type (2021–2026)
Table 57. Global Erlotinib Generics Revenue Market Share by Type (2027–2032)
Table 58. Global Erlotinib Generics Price (US$/Unit) by Type (2021–2026)
Table 59. Global Erlotinib Generics Price (US$/Unit) by Type (2027–2032)
Table 60. Global Erlotinib Generics Sales (K Units) by Application (2021–2026)
Table 61. Global Erlotinib Generics Sales (K Units) by Application (2027–2032)
Table 62. Global Erlotinib Generics Sales Market Share by Application (2021–2026)
Table 63. Global Erlotinib Generics Sales Market Share by Application (2027–2032)
Table 64. Global Erlotinib Generics Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Erlotinib Generics Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Erlotinib Generics Revenue Market Share by Application (2021–2026)
Table 67. Global Erlotinib Generics Revenue Market Share by Application (2027–2032)
Table 68. Global Erlotinib Generics Price (US$/Unit) by Application (2021–2026)
Table 69. Global Erlotinib Generics Price (US$/Unit) by Application (2027–2032)
Table 70. Teva Company Information
Table 71. Teva Description and Business Overview
Table 72. Teva Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Teva Erlotinib Generics Product
Table 74. Teva Recent Developments/Updates
Table 75. Mylan Company Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Mylan Erlotinib Generics Product
Table 79. Mylan Recent Developments/Updates
Table 80. Glenmark Pharmaceuticals Company Information
Table 81. Glenmark Pharmaceuticals Description and Business Overview
Table 82. Glenmark Pharmaceuticals Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Glenmark Pharmaceuticals Erlotinib Generics Product
Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
Table 85. Cipla Company Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Cipla Erlotinib Generics Product
Table 89. Cipla Recent Developments/Updates
Table 90. Natco Pharma Company Information
Table 91. Natco Pharma Description and Business Overview
Table 92. Natco Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Natco Pharma Erlotinib Generics Product
Table 94. Natco Pharma Recent Developments/Updates
Table 95. Aristopharma Company Information
Table 96. Aristopharma Description and Business Overview
Table 97. Aristopharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Aristopharma Erlotinib Generics Product
Table 99. Aristopharma Recent Developments/Updates
Table 100. Taj Pharma Company Information
Table 101. Taj Pharma Description and Business Overview
Table 102. Taj Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Taj Pharma Erlotinib Generics Product
Table 104. Taj Pharma Recent Developments/Updates
Table 105. Sun Pharmaceutical Company Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sun Pharmaceutical Erlotinib Generics Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Jilin Aodong Taonan Pharmaceutical Company Information
Table 111. Jilin Aodong Taonan Pharmaceutical Description and Business Overview
Table 112. Jilin Aodong Taonan Pharmaceutical Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Jilin Aodong Taonan Pharmaceutical Erlotinib Generics Product
Table 114. Jilin Aodong Taonan Pharmaceutical Recent Developments/Updates
Table 115. Acebright Pharma Company Information
Table 116. Acebright Pharma Description and Business Overview
Table 117. Acebright Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Acebright Pharma Erlotinib Generics Product
Table 119. Acebright Pharma Recent Developments/Updates
Table 120. Shandong Loncom Pharma Company Information
Table 121. Shandong Loncom Pharma Description and Business Overview
Table 122. Shandong Loncom Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Shandong Loncom Pharma Erlotinib Generics Product
Table 124. Shandong Loncom Pharma Recent Developments/Updates
Table 125. Hansoh Pharma Company Information
Table 126. Hansoh Pharma Description and Business Overview
Table 127. Hansoh Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Hansoh Pharma Erlotinib Generics Product
Table 129. Hansoh Pharma Recent Developments/Updates
Table 130. Thery Pharm Company Information
Table 131. Thery Pharm Description and Business Overview
Table 132. Thery Pharm Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Thery Pharm Erlotinib Generics Product
Table 134. Thery Pharm Recent Developments/Updates
Table 135. Shenzhen Salubris Pharmaceuticals Company Information
Table 136. Shenzhen Salubris Pharmaceuticals Description and Business Overview
Table 137. Shenzhen Salubris Pharmaceuticals Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Shenzhen Salubris Pharmaceuticals Erlotinib Generics Product
Table 139. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Erlotinib Generics Distributors List
Table 143. Erlotinib Generics Customers List
Table 144. Erlotinib Generics Market Trends
Table 145. Erlotinib Generics Market Drivers
Table 146. Erlotinib Generics Market Challenges
Table 147. Erlotinib Generics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Erlotinib Generics
Figure 2. Global Erlotinib Generics Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Erlotinib Generics Market Share by Type: 2025 & 2032
Figure 4. 25mg per Tablet Product Picture
Figure 5. 100mg per Tablet Product Picture
Figure 6. 150mg per Tablet Product Picture
Figure 7. Global Erlotinib Generics Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Erlotinib Generics Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Erlotinib Generics Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Erlotinib Generics Market Size (US$ Million), 2021–2032
Figure 14. Global Erlotinib Generics Sales (K Units), 2021–2032
Figure 15. Global Erlotinib Generics Average Price (US$/Unit), 2021–2032
Figure 16. Erlotinib Generics Report Years Considered
Figure 17. Erlotinib Generics Sales Share by Manufacturers in 2025
Figure 18. Global Erlotinib Generics Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Erlotinib Generics Players: Market Share by Revenue in Erlotinib Generics in 2025
Figure 20. Erlotinib Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Erlotinib Generics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Erlotinib Generics Sales Market Share by Country (2021–2032)
Figure 23. North America Erlotinib Generics Revenue Market Share by Country (2021–2032)
Figure 24. United States Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Erlotinib Generics Sales Market Share by Country (2021–2032)
Figure 27. Europe Erlotinib Generics Revenue Market Share by Country (2021–2032)
Figure 28. Germany Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Erlotinib Generics Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Erlotinib Generics Revenue Market Share by Region (2021–2032)
Figure 35. China Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Erlotinib Generics Sales Market Share by Country (2021–2032)
Figure 43. Latin America Erlotinib Generics Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Erlotinib Generics Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Erlotinib Generics Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Erlotinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Erlotinib Generics by Type (2021–2032)
Figure 54. Global Revenue Market Share of Erlotinib Generics by Type (2021–2032)
Figure 55. Global Erlotinib Generics Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Erlotinib Generics by Application (2021–2032)
Figure 57. Global Revenue Market Share of Erlotinib Generics by Application (2021–2032)
Figure 58. Global Erlotinib Generics Price (US$/Unit) by Application (2021–2032)
Figure 59. Erlotinib Generics Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
